Andy Studna

In this podcast, Ira C. Spector, PhD, MBA, CEO and Co-Founder, SFA Therapeutics, discusses how his career journey has epitomized the ability to solve problems, which is essentially the role of drug development. It has also led to the formation and strategic approach to his company’s early-stage clinical trials for using the microbiome to address chronic inflammatory diseases.

Podcasts

Ira C. Spector, PhD, MBA, CEO and Co-Founder, SFA Therapeutics discusses how his career journey has epitomized the ability to solve problems, which is essentially the role of drug development. It has also led to the formation and strategic approach to his company’s early-stage clinical trials for using the microbiome to address chronic inflammatory diseases.

Treat Disease, Not the Symptoms

Beth MacEntee Pileggi, Head of Global Case and Safety Data Management with Janssen Pharmaceuticals of Johnson & Johnson, and Co-Lead of TransCelerate’s Pharmacovigilance Agreements Optimization Initiative, discusses the importance of safety, collaboration, TransCelerate’s positive role in the pharma industry and her passion for PV.

A Passion For Pharmacovigilance- Keeping Patients Safe

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Melissa Easy, VP and GM, clinical technologies at IQVIA dicusses how tehcnology and data can be used more effectively in supporting patients throughout clinical trials.

Articles

Melissa Easy, VP and GM, clinical technologies at IQVIA speaks about concerns with clinical technology at the SCOPE 2023 conference in Orlando, FL.

SCOPE 2023: Concerns With Clinical Technology

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Melissa Easy, VP and GM, clinical technologies at IQVIA talks about how clinops professionals can effectively fit new forms of technology into their ecosystems and the importance of data heading into 2023.

Melissa Easy, VP and GM, clinical technologies at IQVIA speaks about what should be top of mind for clinops professionals in 2023 at the SCOPE 2023 conference in Orlando, FL.

SCOPE 2023: Concerns for Clinical Operations Professionals in 2023

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures talks about his recently-founded company and its mission to reduce readmissions for high-risk patients with chronic diseases using voice-enabled natural language processing technology.

Sunny Kumar, MD, partner at GSR Ventures speaks about reducing hospital readmissions for high-risk patients at the SCOPE 2023 conference in Orlando, FL.

SCOPE 2023: Reducing Readmissions in High-Risk Patients

In an interview at the 2023 SCOPE conference with ACT editor, Andy Studna, Sunny Kumar, MD, partner at GSR Ventures discusses how 2023 could be a year of resurgence for venture dollars in clinical research following some retrenchment in 2022.

Sunny Kumar, MD, partner at GSR Ventures speaks about venture capital in clinical research at the SCOPE 2023 conference in Orlando, FL.